skip to content

Press Releases

Emmaus Life Sciences’ Real World Data on Endari Accepted for E-Poster at the 62nd Annual Scientific Meeting of the British Society for HaematologyMarch 04, 2022

Emmaus Life Sciences, Inc. today announced that real world data on Endari®, the company’s prescription-grade L-glutamine oral powder for the treatment of sickle cell disease, has been accepted for an e-poster at the 62nd Annual Meeting of the British Society for Haematology (BSH) to be held April 3 -5, 2022 at the Manchester Central in Manchester, England and virtually.

Read More